FROBEN-SR CAP 200MG DIN 00863882
Health Canada record
| Active ingredient(s) | FLURBIPROFEN 200 MG |
|---|---|
| Dosage form | Capsule (Sustained-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M01AE09 FLURBIPROFEN |
| Original market date | 31-Dec-1990 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
Establishment licence of the holder
Organon Canada Inc. — licence 3-002674, currently licensed, last inspection rating C (2025-11-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLURBIPROFEN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01912038 | FLURBIPROFEN | AA PHARMA INC | Tablet | FLURBIPROFEN 100 MG | Marketed |
| 01912046 | FLURBIPROFEN | AA PHARMA INC | Tablet | FLURBIPROFEN 50 MG | Marketed |
| 00600792 | ANSAID TABLETS 100 MG | PFIZER CANADA ULC | Tablet | FLURBIPROFEN 100 MG | Cancelled Post Market |
| 00647942 | ANSAID TABLETS 50 MG | PFIZER CANADA ULC | Tablet | FLURBIPROFEN 50 MG | Cancelled Post Market |
| 01947737 | FLURBIPROFEN-100 TAB 100MG | PRO DOC LIMITEE | Tablet | FLURBIPROFEN 100 MG | Cancelled Post Market |
| 01947729 | FLURBIPROFEN-50 TAB 50MG | PRO DOC LIMITEE | Tablet | FLURBIPROFEN 50 MG | Cancelled Post Market |
| 02223074 | FROBEN | ABBOTT LABORATORIES, LIMITED | Tablet | FLURBIPROFEN 100 MG | Cancelled Post Market |
| 02223066 | FROBEN | ABBOTT LABORATORIES, LIMITED | Tablet | FLURBIPROFEN 50 MG | Cancelled Post Market |
| 02223082 | FROBEN SR | ABBOTT LABORATORIES, LIMITED | Capsule (Sustained-Release) | FLURBIPROFEN 200 MG | Cancelled Post Market |
| 00593354 | FROBEN TAB 100MG | ORGANON CANADA LTD LTEE | Tablet | FLURBIPROFEN 100 MG | Cancelled Post Market |
| 00593346 | FROBEN TAB 50MG | ORGANON CANADA LTD LTEE | Tablet | FLURBIPROFEN 50 MG | Cancelled Post Market |
| 02237859 | NOVO-FLURPROFEN SR | NOVOPHARM LIMITED | Capsule (Sustained-Release) | FLURBIPROFEN 200 MG | Cancelled Pre Market |
| 02020688 | NU-FLURBIPROFEN TAB 100MG | NU-PHARM INC | Tablet | FLURBIPROFEN 100 MG | Cancelled Post Market |
| 02020661 | NU-FLURBIPROFEN TAB 50MG | NU-PHARM INC | Tablet | FLURBIPROFEN 50 MG | Cancelled Post Market |
| 00675199 | RATIO-FLURBIPROFEN TABLETS 100MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | FLURBIPROFEN 100 MG | Cancelled Post Market |
| 00675202 | RATIO-FLURBIPROFEN TABLETS 50MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | FLURBIPROFEN 50 MG | Cancelled Post Market |
| 02100517 | TEVA-FLURBIPROFEN | TEVA CANADA LIMITED | Tablet | FLURBIPROFEN 100 MG | Cancelled Post Market |
| 02100509 | TEVA-FLURBIPROFEN | TEVA CANADA LIMITED | Tablet | FLURBIPROFEN 50 MG | Cancelled Post Market |
International API supply for FLURBIPROFEN
7 valid EDQM Certificates of Suitability from 7 holders. 9 active FDA Drug Master Files.
Request a quote for FROBEN-SR CAP 200MG